SK-306

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSK-306
Drug Alias NameSK-306
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDihydropteroate synthase inhibitors
TargetsDihydropteroate synthase
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSato Pharmaceutical Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSato Pharmaceutical Ltd
Active IndicationsN/A
Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A